In cancer cells in vitro and in xenotransplanted animal models, one of these small peptides, the ADH-1, enhanced antitumor activity of melphalan-treated melanomas [141] by altering both homotypic (between cancer cells) and heterotypic (between cancer cells and surrounding endothelial cells) cadherin interactions. The gene discussed is ADH1A; the disease is cancer.